For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230413:nRSM1147Wa&default-theme=true
RNS Number : 1147W Cadence Minerals PLC 13 April 2023
Cadence Minerals Plc
("Cadence Minerals", "Cadence", or "the Company")
Notice of Initial Substantial Shareholder in Evergreen Lithium Limited
Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) has filed its Notice of Initial
Substantial Shareholder in Evergreen Lithium Limited ("Evergreen"), a copy of
which can be found here
(https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02653934-6A1144996?access_token=83ff96335c2d45a094df02a206a39ff4)
. Cadence holds 15,830,138 million shares, equivalent to 8.74% of the issued
share capital of Evergreen and is its largest shareholder. Evergreen was
listed on the Australian Stock Exchange on 11 April 2023.
Highlights:
Ø Cadence holds 8.74% of Evergreen Lithium and is its largest shareholder.
Ø Evergreen intends to advance three hard rock lithium exploration projects
in Australia.
Ø Evergreen has listed with approximately AS$ 10 million cash in hand.
Ø The flagship Byone Lithium Project covers the north-eastern strike extent
of the lithium-and tantalum endowed Bynoe Pegmatite field;
o The project is adjacent to Core Lithium's producing lithium mine.
o Soil sampling on the project returned geochemical anomalies indicating
lithium mineralisation.
o Based on soil sampling alone, an initial five target zones containing
lithium mineralisation have been identified.
Ø The second prospect, Kenny Lithium, is located within the Dundas Mineral
Field of Western Australia, close to Mt Dean and Mt Belches-Bald Hill
pegmatite fields.'
o Initial field mapping on the project has confirmed the presence of
substantial outcropping pegmatites
o 10km zone of pegmatite outcropping has been confirmed in the
North-Eastern section of the Kenny Lithium Project
o Evergreen has recently completed a comprehensive auger program, drilling
1,731 holes. Evergreen expects the results to be available shortly after
admission.
Background to Cadence's investment in Evergreen Lithium
Cadence Minerals received approximately 15.8 million shares in Evergreen in
July 2022 when Cadence sold its 31.5% stake in Lithium Technologies and
Lithium Supplies ("LT and LS") to Evergreen as announced on 27 June 2022. A
further AS$ 3.47 million (£1.86 million) of shares in Evergreen are due to
Cadence on the achievement of certain performance milestones by Evergreen. The
pricing of Evergreen shares associated with this consideration is based on a
defined pricing mechanism linked to the VWAP and the date at which the
performance milestones are achieved. Further details of these milestones can
be found in the Evergreen prospectus available here
(https://evergreenlithium.com.au/prospectus/) . Cadence's shares are subject
to a 2-year escrow agreement as determined by the listing rules of the ASX.
For further information contact:
Cadence Minerals plc +44 (0) 20 3582 6636
Andrew Suckling
Kiran Morzaria
WH Ireland Limited (NOMAD & Broker) +44 (0) 207 220 1666
James Joyce
Darshan Patel
- Ends -
Qualified Person
Kiran Morzaria B.Eng. (ACSM), MBA, has reviewed and approved the information
contained in this announcement. Kiran holds a Bachelor of Engineering
(Industrial Geology) from the Camborne School of Mines and an MBA (Finance)
from CASS Business School.
Forward-Looking Statements:
Certain statements in this announcement are or may be deemed to be
forward-looking statements. Forward-looking statements are identified by
their use of terms and phrases such as ''believe'' ''could'' "should"
''envisage'' ''estimate'' ''intend'' ''may'' ''plan'' ''will'' or the negative
of those variations or comparable expressions including references to
assumptions. These forward-looking statements are not based on historical
facts but rather on the Directors' current expectations and assumptions
regarding the Company's future growth results of operations performance future
capital and other expenditures (including the amount. nature and sources of
funding thereof) competitive advantages business prospects and opportunities.
Such forward-looking statements reflect the Directors' current beliefs and
assumptions and are based on information currently available to the
Directors. Many factors could cause actual results to differ materially from
the results discussed in the forward-looking statements including risks
associated with vulnerability to general economic and business conditions
competition environmental and other regulatory changes actions by governmental
authorities the availability of capital markets reliance on key personnel
uninsured and underinsured losses and other factors many of which are beyond
the control of the Company. Although any forward-looking statements contained
in this announcement are based upon what the Directors believe to be
reasonable assumptions. The Company cannot assure investors that actual
results will be consistent with such forward-looking statements.
This announcement contains inside information for the purposes of Article 7 of
the UK version of Regulation (EU) No 596/2014 which is part of UK law by
virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon
the publication of this announcement via a Regulatory Information Service,
this inside information is now considered to be in the public domain.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCGRGDSUUBDGXX